Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans

Psychopharmacology

Volumn 213, Issue 1, 2011, Pages 61-68

  Sofuoglu, Mehmet ^e   Mooney, Marc ^a   Kosten, Thomas ^b   Waters, Andrew ^c   Hashimoto, Kenji ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d CHIBA UNIVERSITY   (Japan)

^e NONE

Author keywords

Dextroamphetamine; Dopamine; Glutamate psychostimulant; Minocycline

Indexed keywords

DEXAMPHETAMINE; HYDROCORTISONE; MINOCYCLINE; PLACEBO;

ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; VELOCITY;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; DEXTROAMPHETAMINE; DRUG INTERACTIONS; FEMALE; HUMANS; HYDROCORTISONE; MALE; MINOCYCLINE; PLACEBOS; REACTION TIME; REWARD; SELF ADMINISTRATION;

EID: 78651256932     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2014-5     Document Type: Article

References (54)

1. MT Bardo 1998 Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens Crit Rev Neurobiol 12 37 67 1:CAS:528:DyaK1cXjslKmug%3D%3D 9444481
2. LH Brauer H de Wit 1996 Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers Biol Psychiatry 39 26 32 1:CAS:528:DyaK28XhtF2jtL0%3D 10.1016/0006-3223(95)00110-7 8719123 (Pubitemid 26024199)
3. C Chaves CR Marque C Trzesniak JP Machado de Sousa AW Zuardi JA Crippa SM Dursun JE Hallak 2009 Glutamate-N-methyl-d-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update Braz J Med Biol Res 42 1002 1014 1:CAS:528:DC%2BC3cXit1Oktg%3D%3D 10.1590/S0100- 879X2009001100002 19855900
4. H Chen T Uz H Manev 2009 Minocycline affects cocaine sensitization in mice Neurosci Lett 452 258 261 1:CAS:528:DC%2BD1MXisFKrtLk%3D 10.1016/j.neulet.2009.01.078 19348734
5. Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20: RC89 (1-5)
6. P Di Ciano BJ Everitt 2001 Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior Neuropsychopharmacology 25 341 360 10.1016/S0893-133X(01)00235-4 11522463 (Pubitemid 32777786)
7. SA Dudish-Poulsen DK Hatsukami 1997 Dissociation between subjective and behavioral responses after cocaine stimuli presentations Drug Alcohol Depend 47 1 9 10.1016/S0376-8716(97)00054-9 9279492 (Pubitemid 27374631)
8. MT Fillmore CR Rush CA Marczinski 2003 Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies Drug Alcohol Depend 71 143 152 1:CAS:528:DC%2BD3sXmsVKnsrs%3D 10.1016/S0376-8716(03)00089-9 12927652 (Pubitemid 37289024)
9. Y Fujita T Ishima S Kunitachi H Hagiwara L Zhang M Iyo K Hashimoto 2008 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline Prog Neuropsychopharmacol Biol Psychiatry 32 336 339 1:CAS:528:DC%2BD1cXhsVKit7Y%3D 10.1016/j.pnpbp.2007.08.031 17884273 (Pubitemid 351178944)
10. JC Gonzalez J Egea GM Del Carmen FJ Fernandez-Gomez J Sanchez-Prieto L Gandia AG Garcia J Jordan JM Hernandez-Guijo 2007 Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons Eur J Neurosci 26 2481 2495 10.1111/j.1460-9568.2007.05873.x 17986028 (Pubitemid 350050444)
11. PH Gordon DH Moore RG Miller JM Florence JL Verheijde C Doorish JF Hilton GM Spitalny RB MacArthur H Mitsumoto HE Neville K Boylan T Mozaffar JM Belsh J Ravits RS Bedlack MC Graves LF McCluskey RJ Barohn R Tandan 2007 Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomised trial Lancet Neurol 6 1045 1053 1:CAS:528:DC%2BD1cXjsF2isQ%3D%3D 10.1016/S1474-4422(07)70270-3 17980667 (Pubitemid 350116691)
12. TA Grady A Broocks SK Canter TA Pigott B Dubbert JL Hill DL Murphy 1996 Biological and behavioral responses to d-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers Psychiatry Res 64 1 10 1:CAS:528:DyaK28XmsValsL8%3D 10.1016/0165-1781(96)02884-3 8888359 (Pubitemid 26298077)
13. M Haney R Spealman 2008 Controversies in translational research: drug self-administration Psychopharmacology (Berl) 199 403 419 1:CAS:528: DC%2BD1cXotVyrsbg%3D 10.1007/s00213-008-1079-x
14. K Hashimoto 2009 Emerging role of glutamate in the pathophysiology of major depressive disorder Brain Res Rev 61 105 123 1:CAS:528:DC%2BD1MXht1WntbvO 10.1016/j.brainresrev.2009.05.005 19481572
15. K Hashimoto H Tsukada S Nishiyama D Fukumoto T Kakiuchi M Iyo 2007 Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys Biol Psychiatry 61 577 581 1:CAS:528:DC%2BD2sXhvVynurc%3D 10.1016/j.biopsych.2006.03.019 16712806 (Pubitemid 46328849)
16. M Imbesi T Uz R Manev RP Sharma H Manev 2008 Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors Neurosci Lett 447 134 137 1:CAS:528:DC%2BD1cXhtlGhurrE 10.1016/j.neulet.2008.10.006 18852022
17. Y Itzhak SF Ali 2006 Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs Pharmacol Ther 109 246 262 1:CAS:528:DC%2BD2MXht12ktbfM 10.1016/j.pharmthera.2005.08.004 16154200 (Pubitemid 41740825)
18. M Jonas BA Cunha 1982 Minocycline Ther Drug Monit 4 137 145 1:CAS:528:DyaL38XkvVCntLw%3D 10.1097/00007691-198206000-00002 7048646
19. PW Kalivas 2007 Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity Dialogues Clin Neurosci 9 389 397 18286799
20. SS Kim PJ Kong BS Kim DH Sheen SY Nam W Chun 2004 Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells Arch Pharm Res 27 314 318 1:CAS:528:DC%2BD2cXivFCmtb4%3D 10.1007/BF02980066 15089037
21. LA Knackstedt PW Kalivas 2009 Glutamate and reinstatement Curr Opin Pharmacol 9 59 64 1:CAS:528:DC%2BD1MXhsFKks78%3D 10.1016/j.coph.2008.12.003 19157986
22. O Kofman E Klein M Newman R Hamburger O Kimchi T Nir H Shimon RH Belmaker 1990 Inhibition by antibiotic tetracyclines of rat cortical noradrenergic adenylate cyclase and amphetamine-induced hyperactivity Pharmacol Biochem Behav 37 417 424 1:CAS:528:DyaK3MXjsFCqug%3D%3D 10.1016/0091-3057(90)90006-4 1965041
23. O Kofman S van Embden C Alpert I Fuchs 1993 Central and peripheral minocycline suppresses motor activity in rats Pharmacol Biochem Behav 44 397 402 1:CAS:528:DyaK3sXhtl2ksro%3D 10.1016/0091-3057(93)90481-8 8383342
24. GF Koob 1992 Neural mechanisms of drug reinforcement Ann NY Acad Sci 654 171 191 1:CAS:528:DyaK38XlvVCisbo%3D 10.1111/j.1749-6632.1992.tb25966.x 1632582
25. Y Lampl M Boaz R Gilad M Lorberboym R Dabby A Rapoport M Anca-Hershkowitz M Sadeh 2007 Minocycline treatment in acute stroke: an open-label, evaluator-blinded study Neurology 69 1404 1410 1:CAS:528:DC%2BD2sXhtVyntbzJ 10.1212/01.wnl.0000277487.04281.db 17909152 (Pubitemid 47511461)
26. PN Leigh V Meininger G Bensimon M Cudkowicz W Robberecht 2008 Minocycline for patients with ALS Lancet Neurol 7 119 120 10.1016/S1474-4422(08)70006-1 18207106 author reply 120-1
27. Y Levkovitz U Levi Y Braw H Cohen 2007 Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia Brain Res 1154 154 162 1:CAS:528:DC%2BD2sXmt1ynsL0%3D 10.1016/j.brainres.2007. 03.080 17488642 (Pubitemid 46856336)
28. Y Levkovitz S Mendlovich S Riwkes Y Braw H Levkovitch-Verbin G Gal S Fennig I Treves S Kron 2009 A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia J Clin Psychiatry 71 138 149 10.4088/JCP.08m04666yel 19895780
29. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258
30. McNair D, Lorr M, Dropperman L (1971) Manual for profile of mood states. Educational and industrial testing services, Educational and industrial testing services
31. H Mizoguchi K Takuma A Fukakusa Y Ito A Nakatani D Ibi HC Kim K Yamada 2008 Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice Psychopharmacology (Berl) 196 233 241 1:CAS:528:DC%2BD1cXpsF2ksQ%3D%3D 10.1007/s00213-007-0955-0
32. M Molina-Hernandez NP Tellez-Alcantara J Perez-Garcia JI Olivera-Lopez MT Jaramillo-Jaimes 2008 Antidepressant-like actions of minocycline combined with several glutamate antagonists Prog Neuropsychopharmacol Biol Psychiatry 32 380 386 1:CAS:528:DC%2BD1cXhsVKitLs%3D 10.1016/j.pnpbp.2007.09.004 17933448 (Pubitemid 351178956)
33. P Munzar H Li KL Nicholson JL Wiley RL Balster 2002 Enhancement of the discriminative stimulus effects of phencyclidine by the tetracycline antibiotics doxycycline and minocycline in rats Psychopharmacology (Berl) 160 331 336 1:CAS:528:DC%2BD38XktFGhtrk%3D 10.1007/s00213-001-0989-7 (Pubitemid 34230685)
34. VK Patchev K Karalis GP Chrousos 1994 Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation Brain Res 633 312 316 1:STN:280:DyaK2c7osVyltw%3D%3D 10.1016/0006-8993(94)91554-7 7907936 (Pubitemid 24021276)
35. PDR (2009) Physicians' Desk Reference: PDR. Medical Economics Data, Medical Economics Data
36. IH Robertson T Manly J Andrade BT Baddeley J Yiend 1997 'Oops!': performance correlates of everyday attentional failures in traumatic brain injured and normal subjects Neuropsychologia 35 747 758 1:STN:280: DyaK2szkvVCksA%3D%3D 10.1016/S0028-3932(97)00015-8 9204482 (Pubitemid 27263222)
37. T Sadowski J Steinmeyer 2001 Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes J Rheumatol 28 336 340 1:CAS:528:DC%2BD3MXhs1Slsr0%3D 11246672
38. LS Seiden KE Sabol GA Ricaurte 1993 Amphetamine: effects on catecholamine systems and behavior Annu Rev Pharmacol Toxicol 33 639 677 1:CAS:528: DyaK3sXks1aitLc%3D 10.1146/annurev.pa.33.040193.003231 8494354
39. M Sofuoglu AJ Waters M Mooney T Kosten 2008 Riluzole and d-amphetamine interactions in humans Prog Neuropsychopharmacol Biol Psychiatry 32 16 22 1:CAS:528:DC%2BD1cXptlWqsw%3D%3D 10.1016/j.pnpbp.2007.05.003 17714844
40. M Sofuoglu J Poling A Waters A Sewell K Hill T Kosten 2008 Disulfiram enhances subjective effects of dextroamphetamine in humans Pharmacol Biochem Behav 90 394 398 1:CAS:528:DC%2BD1cXmvV2ks70%3D 10.1016/j.pbb.2008.03.021 18474395
41. M Sofuoglu AJ Waters M Mooney SS O'Malley 2009 Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans Pharmacol Biochem Behav 92 135 140 1:CAS:528: DC%2BD1MXhtlOmt7o%3D 10.1016/j.pbb.2008.11.004 19041336
42. Stoops WW, Glaser PE, Fillmore MT, Rush CR (2004) Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18:534-543
43. Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR (2005) Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) 177:349-355
44. Tanibuchi Y, Shimagami M, Fukami G, Sekine Y, Iyo M, Hashimoto K (2010) A case of methamphetamine use disorder treated with the antibiotic drug minocycline. Gen Hosp Psychiatry (in press)
45. The NINDS NET-PD Investigators 2006 A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease Neurology 66 664 671 10.1212/01.wnl.0000201252.57661.e1 (Pubitemid 43739819)
46. MJ Thomas PW Kalivas Y Shaham 2008 Neuroplasticity in the mesolimbic dopamine system and cocaine addiction Br J Pharmacol 154 327 342 1:CAS:528:DC%2BD1cXlvVWnsr8%3D 10.1038/bjp.2008.77 18345022 (Pubitemid 351670603)
47. JW Tidey SC O'Neill ST Higgins 2000 d-Amphetamine increases choice of cigarette smoking over monetary reinforcement Psychopharmacology (Berl) 153 85 92 1:CAS:528:DC%2BD3MXhtlGisL4%3D 10.1007/s002130000600 (Pubitemid 32127906)
48. TM Tzschentke 2001 Pharmacology and behavioral pharmacology of the mesocortical dopamine system Prog Neurobiol 63 241 320 1:CAS:528: DC%2BD3cXoslCks7o%3D 10.1016/S0301-0082(00)00033-2 11115727
49. TM Tzschentke WJ Schmidt 2003 Glutamatergic mechanisms in addiction Mol Psychiatry 8 373 382 1:CAS:528:DC%2BD3sXjsFOjurw%3D 10.1038/sj.mp.4001269 12740594 (Pubitemid 36609661)
50. MA Ungless JL Whistler RC Malenka A Bonci 2001 Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons Nature 411 583 587 1:CAS:528:DC%2BD3MXksVShsr4%3D 10.1038/35079077 11385572 (Pubitemid 32531404)
51. P Vezina AL Queen 2000 Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area Psychopharmacology (Berl) 151 184 191 1:CAS:528: DC%2BD3cXmtFyks7s%3D 10.1007/s002130000463
52. ND Volkow GJ Wang JS Fowler J Logan SJ Gatley R Hitzemann AD Chen SL Dewey N Pappas 1997 Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects Nature 386 830 833 1:CAS:528:DyaK2sXivVGjtbc%3D 10.1038/386830a0 9126741
53. L Zhang K Kitaichi Y Fujimoto H Nakayama E Shimizu M Iyo K Hashimoto 2006 Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine Prog Neuropsychopharmacol Biol Psychiatry 30 1381 1393 1:CAS:528:DC%2BD28XhtFCjsLjF 10.1016/j.pnpbp.2006.05.015 16839653 (Pubitemid 44634942)
54. DR Ziegler WE Cullinan JP Herman 2005 Organization and regulation of paraventricular nucleus glutamate signaling systems: N-methyl-d-aspartate receptors J Comp Neurol 484 43 56 1:CAS:528:DC%2BD2MXis1Gmurw%3D 10.1002/cne.20445 15717303 (Pubitemid 40315404)